Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

AstraZeneca, BMS Plan Job Cuts

July 30, 2007 | A version of this story appeared in Volume 85, Issue 31

AstraZeneca has announced another round of job eliminations to complement the cut of 3,000 manufacturing jobs it announced earlier this year. The British drugmaker now says it will eliminate about 700 positions in R&D, 1,800 positions in sales and marketing, and 1,800 positions in information systems and business support. Separately, Bristol-Myers Squibb said last week that it will announce job cuts and facilities closures later this year as part of its own streamlining effort.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.